Study of MT-302 in Adults With Advanced or Metastatic Epithelial Tumors

NIAID Data Ecosystem2026-05-01 收录

癌症药物临床试验

上皮癌靶向治疗

数据链接：

https://www.omicsdi.org/dataset/ecrin-mdr-crc/68117 数据链接链接失效反馈

官方服务：

资源简介：

MYE Symphony is a multicenter, open-label, Phase 1 first-in-human study to assess the safety, tolerability, and define the RP2D of MT-302 in participants with advanced epithelial cancer.

创建时间：

2023-08-15

Table_1_Randomized placebo-controlled double-blind phase II study of zaltoprofen for patients with diffuse-type and unresectable localized tenosynovial giant cell tumors: The REALIZE study.xlsx

腱鞘巨细胞瘤治疗

癌症药物临床试验

BackgroundA tenosynovial giant cell tumor (TGCT) is a locally aggressive benign neoplasm arising from intra- or extra-articular tissue, categorized as localized (L-TGCT, solitary lesion) and diffuse (

NIAID Data Ecosystem30

A Study of MDX-1106 in Patients With Selected Refractory or Relapsed Malignancies

癌症药物临床试验

癌症治疗响应

To evaluate the safety, tolerability, efficacy, and pharmacokinetics of MDX-1106 when administered to patients with advanced non-small cell lung cancer, colorectal cancer, malignant melanoma, clear ce

NIAID Data Ecosystem20

CCR Translation for This Article from Phase II Efficacy and Pharmacogenomic Study of Selumetinib (AZD6244; ARRY-142886) in Iodine-131 Refractory Papillary Thyroid Carcinoma with or without Follicular Elements

癌症药物临床试验

药物基因组学

CCR Translation for This Article from Phase II Efficacy and Pharmacogenomic Study of Selumetinib (AZD6244; ARRY-142886) in Iodine-131 Refractory Papillary Thyroid Carcinoma with or without Follicular

NIAID Data Ecosystem00

Supplementary Material for: Phase I Dose-Escalation and Pharmacokinetic Study of Intravenous Aflibercept in Combination with Docetaxel, Cisplatin, and 5-Fluorouracil in Patients with Advanced Solid Malignancies

癌症药物临床试验

药代动力学

Purpose: This phase I study (EudraCT No. 2006-001177-25) investigated aflibercept, a vascular endothelial growth factor decoy receptor protein (VEGF Trap), in combination with docetaxel, cisplatin, an

NIAID Data Ecosystem30

Dataset from A First-in-human Phase Ia/b, Open Label, Multicentre, Dose Escalation Study of BI 905711 in Patients With Advanced Gastrointestinal Cancers

癌症药物临床试验

剂量递增研究

Phase 1a - Explore safety and establish the maximum tolerated dose (MTD)/recommended dose levels for phase Ib expansion phase of BI 905711 based on the frequency of patients experiencing dose limiting

NIAID Data Ecosystem10

Study of MT-302 in Adults With Advanced or Metastatic Epithelial Tumors

资源简介：

相关数据集